Kim LufkinGHTC
Kim Lufkin is a communications officer at GHTC.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Mozambique has completed its first HIV vaccine trial and is set to begin a second, demonstrating the country’s increased research capacity.
The Global Alliance for TB Drug Development and UNITAID are calling for more action against childhood tuberculosis (TB), including research to create new and improved pediatric treatments.
Officials with the Walter Reed Army Institute of Research say that sequestration will affect further testing of a potentially cutting-edge malaria vaccine.
New trials are being plannedfollowing news that a toddler in Mississippi has been functionally cured of HIV.
The US Agency for International Development has announced that its contractors could see current or future funding reduced as a result of sequestration.